Biovara
Developing an oral therapy for lung cancer cough for patients with advanced lung cancer
Highlights
- Young companyFounded 2025
- New on EvolcAdded 2026-11-09
About Biovara
Biovara is developing LipAprep, an orally administered therapy intended to treat chronic cough associated with advanced lung cancer. The company says its approach targets causes in both the brain and the lung.
Biovara was founded in 2025 and is headquartered in London, United Kingdom. Its leadership team includes pharmaceutical development and oncology experience.
Product: LipAprep, an oral therapy in development for lung cancer cough.
Jobs at Biovara
Leadership
- Simon Yaxley · Chief Executive Officer (CEO)Source: company website
- George Style · Interim Chief Financial Officer (CFO)Source: company website
More biotech & pharma companies
Biowaived
Biopharmaceutics consultancy and dissolution laboratory services for pharma and biotech drug product developmentYoung companyNew on EvolcBlackfinbio
Develops gene therapies for patients with rare and other central nervous system diseasesYoung companyNew on EvolcBlacksheep Sciences
Engineering and product-development services for life science and biotech teams building instruments and microfluidic platformsYoung companyNew on EvolcBlue Earth Diagnostics
Develops and commercialises PET molecular imaging agents for cancer and cardiology, used by clinicians and patientsNew on EvolcSalary transparentBlue Earth Therapeutics
Clinical-stage radiopharmaceutical developer targeting prostate cancer with PSMA-targeted radiohybrid therapiesNew on EvolcBounce Biomedical
Develops regenerative implants for patients with cartilage and bone injuries in jointsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Gravity FormsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Privacy & consent
- CookieYesHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.